The effects of metabolic inhibitors on the autohaemolysis test and its relevance to the mechanism of the red cell lysis.
D000255:Adenosine Triphosphate / Q000494:pharmacology; D000328:Adult; D000745:Anemia, Hemolytic, Congenital / Q000097:blood; D000963:Antimetabolites / Q000494:pharmacology; D001386:Azides / Q000494:pharmacology; D004163:Diphosphoglyceric Acids / Q000097:blood; D004912:Erythrocytes / Q000187:drug effects; D005033:Ethylmaleimide / Q000494:pharmacology; D005260:Female; D005459:Fluorides / Q000494:pharmacology; D006019:Glycolysis; D006366:Heinz Bodies; D006461:Hemolysis / Q000187:drug effects; D006493:Heparin / Q000494:pharmacology; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D010428:Pentosephosphates / Q000097:blood; D011770:Pyruvate Kinase; D012964:Sodium / Q000097:blood
D000963:Antimetabolites; D001386:Azides; D004163:Diphosphoglyceric Acids; D010428:Pentosephosphates; D000255:Adenosine Triphosphate; D006493:Heparin; D012964:Sodium; D011770:Pyruvate Kinase; D005033:Ethylmaleimide; D005459:Fluorides